On Wednesday, Masimo earned an upgrade to its Relative Strength (RS) Rating, from 68 to 72.
Can You Really Time The Stock Market?
This exclusive rating from Investor's Business Daily tracks share price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an RS Rating of over 80 in the early stages of their moves. See if Masimo can continue to rebound and hit that benchmark.
Masimo is building a consolidation with a 194.88 buy point. See if the stock can break out in heavy volume.
In terms of fundamental health, the company has posted four quarters of rising earnings growth. Sales gains have also moved higher during the same period.
The company holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Intuitive Surgical, Brainsway ADR and iRadimed are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
